Home » Stocks » Evofem Biosciences

Evofem Biosciences, Inc. (EVFM)

Stock Price: $2.93 USD 0.03 (1.03%)
Updated Aug 7, 2020 4:00 PM EDT - Market closed
After-hours: $2.90 -0.03 (-1.02%) Aug 7, 7:58 PM

Stock Price Chart

Key Info

Market Cap 229.19M
Revenue (ttm) n/a
Net Income (ttm) -98.33M
Shares Out 81.28M
EPS (ttm) -1.94
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Aug 7, 2020
Last Price $2.93
Previous Close $2.90
Change ($) 0.03
Change (%) 1.03%
Day's Open 2.91
Day's Range 2.80 - 2.94
Day's Volume 2,922,521
52-Week Range 2.73 - 7.50

More Stats

Market Cap 229.19M
Enterprise Value 154.99M
Earnings Date (est) Nov 4, 2020
Ex-Dividend Date n/a
Shares Outstanding 81.28M
Float 79.96M
EPS (basic) -1.77
EPS (diluted) -1.94
FCF / Share -1.01
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 2.47M
Short Ratio 0.94
Short % of Float 8.07%
Beta -0.65
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio n/a
PB Ratio 230.47
Revenue n/a
Operating Income -68.79M
Net Income -98.33M
Free Cash Flow -58.47M
Net Cash 74.20M
Net Cash / Share 0.95
Gross Margin n/a
Operating Margin n/a
Profit Margin n/a
FCF Margin n/a
ROA -45.38%
ROE -188.49%
ROIC 2,333.20%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (3)

Buy 3
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

(411.95% upside)
Current: $2.93
Target: 15.00
*Average 12-month price target from 3 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Gross Profit-------0.10
Operating Income-52.74-77.64-35.69-12.04-42.05-9.59-14.42-5.74
Net Income-80.03-126-105-13.02-43.16-10.82-15.02-7.83
Shares Outstanding40.2321.901.962.302.280.340.090.08
Earnings Per Share-1.99-5.74-55.78-5.66-18.91-32.16-175.98-93.90
Operating Cash Flow-55.10-56.50-19.24-16.25-37.91-9.57-12.90-7.40
Capital Expenditures-0.13-0.01-0.01--0.23-0.020.04-
Free Cash Flow-55.23-56.51-19.25-16.25-38.14-9.59-12.86-7.40
Cash & Equivalents24.111.761.7011.6837.9575.954.3611.14
Total Debt0.204.01--9.969.740.210.63
Net Cash / Debt23.91-2.251.7011.6827.9966.214.1610.51
Book Value15.64-23.36-29011.9123.8165.25-56.69-41.76
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Evofem Biosciences, Inc.
Country United States
Employees 53
CEO Saundra L. Pelletier

Stock Information

Ticker Symbol EVFM
Stock Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Unique Identifier NASDAQ: EVFM


Evofem Biosciences, Inc., a biopharmaceutical company, develops and commercializes various products to address unmet needs in women's sexual and reproductive health. Its commercial product is Phexxi, a vaginal gel for the prevention of pregnancy. The company is also involved in the development of EVO100, a vaginal pH regulator for the prevention of urogenital transmission of Chlamydia trachomatis infection and Neisseria gonorrhoeae infection in women. Evofem Biosciences, Inc. is headquartered in San Diego, California.